Alvotech

ALVO.IC·Iceland·Healthcare
Compare
562.00+4.00 (+0.72%)today
As of Nov 5, 12:07 PM GMT · May be delayed up to 15 min · ISK

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close558.00
Open562.00
Day range562.00566.00
52-week range364.00800.00
Off day high−0.71%
Off 52-week high−29.75%
Volume2.52K
Avg. volume (3M)160.93K
Market cap200.53B
EPS (TTM)-77.75
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.24
Shares outstanding356.82M
Short interest—
Earnings dateNov 11, 2026
Analyst target—
Profit margin−36.31%

Against its peers

Compare in full ›
ALVO.IC MOREPENLAB.NS GLENMARK.NS SOLARA.NS B6E.F ALKS
Market cap 200.53B 53.21B 700.43B 31.04B 15.44B 7.71B
P/E (TTM) — 28.3 39.0 83.4 25.6 —
Forward P/E — — 25.6 20.5 — 25.4
Price/book -1,046.6 3.9 6.7 2.2 0.4 4.1
Dividend yield — 0.20% 0.20% — — —
1-year change −15.45% +113.46% +38.35% +14.61% +44.42% +44.85%
Today +0.72% −4.17% −0.91% −0.25% +1.98% +0.44%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Latest news

All ALVO.IC news ›
Eyes On Eyecare·Positive

Alcon acquires Neurotech, MacTel therapy Encelto

Alcon, Inc. has purchased Neurotech Pharmaceuticals, Inc., developer of the first and only FDA-approved treatment for Macular Telangiectasia Type 2 (MacTel). Alcon shared two details surrounding the transaction: Headquartered in…

Stock Titan·Positive

Alvotech: SIMLANDI output per batch more than doubles

Rapport Therapeutics Announces Positive Topline Results from its Phase 2 Trial of RAP-219 for the Treatment of Bipolar Mania Fort Technology: Logia USA Signs Exclusive Distribution Agreement to Expand Fuel Maintenance Solutions for Data…

MarketScreener··2 outlets

Alvotech And Advanz Pharma Holdco Limited Submit European Regulatory Application For AVT29, Proposed Biosimilar To Eylea 8 Mg

Alvotech and Advanz Pharma announced the submission of a European regulatory application for AVT29, a proposed biosimilar to Eylea® 8 mg , which is marketed as Eylea HD® in the United States. Based... Alvotech and Advanz Pharma announced…

LLY
More from 1 other outlet

From the 4Search news index, newest first.

In the news

69mentions in 30 days
60with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 69 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance